The Korean Journal of Medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지

Recent Update of Pathology of the Pancreatic Neuroendocrine Tumor

췌장 신경내분비 종양의 병리학적 최신 지견

  • Jin, So-Young (Department of Pathology, Soonchunhyang University Hospital)
  • 진소영 (순천향대학교병원 병리과)
  • Published : 2011.04.01
⟨ Previous Next ⟩

Abstract

Pancreas is an endocrine organ as well as an exocrine one. The pancreatic neuroendocrine tumor (PNET) is an epithelial tumor with features of endocrine differentiation. Its incidence is progressively increasing now. Because the prognosis of PNET is much better than that of ductal adenocarcinoma, the precise diagnosis and proper treatment is more important than ever. Recently World Health Organization (WHO) and American Joint Committee on Cancer (AJCC) published the new WHO 2010 classification and the unified staging system of the PNET unlike the other gastrointestinal tract. Here, recent update of pathology of PNET will be discussed with their basic morphologic characteristics and essential points in the pathology report.

Keywords

References

  1. Klimstra DS, Arnold R, Capella C, et al. Neuroendocrine neoplasms of the pancreas. In: Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. 4th ed. Lyon: International Agency for Research on Cancer, 2010:322-326.
  2. Kimura W, Kuroda A, Morioka Y. Clinical pathology of endocrine tumors of the pancreas: analysis of autopsy cases. Dig Dis Sci 1991;36:933-942. https://doi.org/10.1007/BF01297144
  3. Bruzoni M, Johnston E, Sasson AR. Pancreatic incidentalomas: clinical and pathologic spectrum. Am J Surg 2008;195:329-332. https://doi.org/10.1016/j.amjsurg.2007.12.027
  4. Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S. The pathologic classification of neuroendocrine tumors: a reivew of nomenclature, grading, and staging systems. Pancreas 2010;39:707-712 https://doi.org/10.1097/MPA.0b013e3181ec124e
  5. Ehehalt F, Saeger HD, Schmidt CM, Grutzmann R. Neuroendocrine tumors of the pancreas. Oncologist 2009;14:456-467. https://doi.org/10.1634/theoncologist.2008-0259
  6. Hochwald SN, Zee S, Conlon KC, et al. Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J Clin Oncol 2002;20:2633-2642. https://doi.org/10.1200/JCO.2002.10.030
  7. Ferrone CR, Tang LH, Tomlinson J, et al. Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified? J Clin Oncol 2007;25:5609-5615. https://doi.org/10.1200/JCO.2007.12.9809
  8. Rindi G, Klöppel G, Alhman H, et al. TNM staging of foregut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2006;449:395-401. https://doi.org/10.1007/s00428-006-0250-1
  9. Schmitt AM, Anlauf M, Rousson V, et al. WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors. Am J Surg Pathol 2007;31;1677-1682. https://doi.org/10.1097/PAS.0b013e31805f675d
  10. Jonkers YM, Claessen SM, Perren A, et al. DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients. Endocr Relat Cancer 2007;14:769-779. https://doi.org/10.1677/ERC-07-0111
  11. Missiaglia E, Moore PS, Williamson J, et al. Sex chromosome anomalies in pancreatic endocrine tumors. Int J Cancer 2002;98:532-538. https://doi.org/10.1002/ijc.10223
  12. Falconi M, Plockinger U, Kwekkeboom DJ, et al. Well-differentiated pancreatic nonfunctioning tumors/carcinoma. Neuroendocrinology 2006;84:196-211. https://doi.org/10.1159/000098012
  13. Dixon E, Pasieka JL. Functioning and nonfunctioning neuroendocrine tumors of the pancreas. Curr Opin Oncol 2007;19:30-35. https://doi.org/10.1097/CCO.0b013e328011a236
  14. El-Bahrawy MA, Rowan A, Horncastle D, et al. E-cadherin/catenin complex status in solid pseudopapillary tumor of the pancreas. Am J Surg Pathol 2008;32:1-7. https://doi.org/10.1097/PAS.0b013e31813e0676
  15. Anlauf M, Garbrecht N, Bauersfeld J, et al. Hereditary neuroendocrine tumors of the gastroenteropancreatic system. Virchows Archiv 2007;451(Suppl 1):S29-S38. https://doi.org/10.1007/s00428-007-0450-3
  16. Vortmeyer AO, Huang S, Lubensky I, Zhuang Z. Non-islet origin of pancreatic islet cell tumors. J Clin Endocrinol Metab 2004;89:1934-1938. https://doi.org/10.1210/jc.2003-031575
  17. Klöppel G, Anlauf M, Perren A. Endocrine precursor lesions of gastroenteropancreatic neuroendocrine tumors. Endocr Pathol 2007;18:150-155. https://doi.org/10.1007/s12022-007-0025-5
  18. Edge SE, Byrd DR, Carducci MA, et al. AJCC cancer staging manual. 7th ed. New York: Springer, 2010.
  19. Franko J, Feng W, Yip L, Genovese E, Moser AJ. Non-functional neuroendocrine carcinoma of the pancreas: incidence, tumor biology, and outcomes in 2,158 patients. J Gastrointest Surg 2010;14:541-548. https://doi.org/10.1007/s11605-009-1115-0